Trial of Ebola drug shows improvement in US but is suspended in China

Posted on

The first results from an international experimental US antiviral drug are promising, even as a trial of the same drug in China shuts down.

More than half of a group of severely ill coronavirus patients from the US, Canada, Europe and Japan improved after taking remdesivir made by California-based Gilead Sciences.

Originally developed as a treatment for Ebola, the medication has been shown to fight against coronaviruses such as severe acute respiratory syndrome (SARS), which is a cousin of the new virus. 

At the same time, a trial in China testing the drug in those with mild symptoms of the virus was suspended due to a lack of eligible patients.

However, some analysts believe that the trial was suspended because the drug was not proved to be effective

The first results of a trial testing remdesivir, a US-made Ebola drug, on severely ill coronavirus patients, was released. Pictured: A vial

Read More